The University of Chicago Header Logo

Connection

Michael P Blair to Angiogenesis Inhibitors

Back to Details
This is a "connection" page, showing publications Michael P Blair has written about Angiogenesis Inhibitors.
Michael P Blair
Connection Strength
4.209
Angiogenesis Inhibitors
  1. Neurodevelopmental Outcomes Comparing Bevacizumab to Laser for Type 1 ROP. Ophthalmic Surg Lasers Imaging Retina. 2019 06 01; 50(6):337-343.
    View in: PubMed
    Score: 0.576
  2. Foveal Development After Use of Bevacizumab for Aggressive Posterior Retinopathy of Prematurity. Ophthalmic Surg Lasers Imaging Retina. 2019 06 01; 50(6):e185-e187.
    View in: PubMed
    Score: 0.576
  3. Very Late Reactivation of Retinopathy of Prematurity After Monotherapy With Intravitreal Bevacizumab. Ophthalmic Surg Lasers Imaging Retina. 2016 Mar; 47(3):280-3.
    View in: PubMed
    Score: 0.460
  4. In reply to Mireskandari and coworkers. JAMA Ophthalmol. 2013 Apr; 131(4):546-7.
    View in: PubMed
    Score: 0.376
  5. Bevacizumab for ROP. Ophthalmology. 2012 Feb; 119(2):431-2; author reply 432.
    View in: PubMed
    Score: 0.347
  6. Fluorescein angiography of recurrent retinopathy of prematurity after initial intravitreous bevacizumab treatment. Arch Ophthalmol. 2010 Aug; 128(8):1080-1.
    View in: PubMed
    Score: 0.312
  7. Two-Year Outcomes Comparing Anti-VEGF Injections to Laser for ROP Using a Commercial Claims Database. Ophthalmic Surg Lasers Imaging Retina. 2020 09 01; 51(9):486-493.
    View in: PubMed
    Score: 0.157
  8. Late visual outcomes in infants treated with primary bevacizumab for type 1 retinopathy of prematurity. J AAPOS. 2020 06; 24(3):149.e1-149.e5.
    View in: PubMed
    Score: 0.154
  9. Refractive outcomes comparing primary laser to primary bevacizumab with delayed laser for type 1 ROP. J AAPOS. 2019 04; 23(2):88.e1-88.e6.
    View in: PubMed
    Score: 0.141
  10. Bilateral Vitreous Hemorrhage Following Bilateral Intravitreal Injections of Bevacizumab in an Infant With Retinopathy of Prematurity. Ophthalmic Surg Lasers Imaging Retina. 2018 11 01; 49(11):893-896.
    View in: PubMed
    Score: 0.138
  11. PROPHYLACTIC PERIPHERAL LASER AND FLUORESCEIN ANGIOGRAPHY AFTER BEVACIZUMAB FOR RETINOPATHY OF PREMATURITY. Retina. 2018 Apr; 38(4):764-772.
    View in: PubMed
    Score: 0.133
  12. Re: Good: Bevacizumab for retinopathy of prematurity: treatment when pathology is embedded in a normally developing vascular system (Ophthalmology. 2016;123:1843-1844). Ophthalmology. 2017 10; 124(10):e74-e75.
    View in: PubMed
    Score: 0.128
  13. Reactivation of Retinopathy of Prematurity Three Years After Treatment With Bevacizumab. Ophthalmic Surg Lasers Imaging Retina. 2017 03 01; 48(3):255-259.
    View in: PubMed
    Score: 0.123
  14. Intravitreal anti-vascular endothelial growth factor for choroidal neovascularization in ocular histoplasmosis. Retin Cases Brief Rep. 2014; 8(1):24-9.
    View in: PubMed
    Score: 0.099
  15. Exudative retinopathy and detachment: a late reactivation of retinopathy of prematurity after intravitreal bevacizumab. J AAPOS. 2013 Jun; 17(3):323-5.
    View in: PubMed
    Score: 0.094
  16. Reactivation of retinopathy of prematurity after bevacizumab injection. Arch Ophthalmol. 2012 Aug; 130(8):1000-6.
    View in: PubMed
    Score: 0.090
  17. Significant treatment failure with intravitreous bevacizumab for retinopathy of prematurity. Arch Ophthalmol. 2012 Jun; 130(6):801-2.
    View in: PubMed
    Score: 0.089
  18. Intravitreal bevacizumab for neovascular glaucoma. J Ocul Pharmacol Ther. 2009 Oct; 25(5):453-8.
    View in: PubMed
    Score: 0.074
  19. Association of Health Insurance Status With Severity and Treatment Among Infants With Retinopathy of Prematurity. J Pediatr Ophthalmol Strabismus. 2023 Nov-Dec; 60(6):e75-e78.
    View in: PubMed
    Score: 0.049
  20. Neurodevelopmental outcomes following bevacizumab treatment for retinopathy of prematurity: a systematic review and meta-analysis. J Perinatol. 2021 09; 41(9):2377-2378.
    View in: PubMed
    Score: 0.042
  21. CONCURRENT SCLERAL BUCKLE AND INTRAVITREAL BEVACIZUMAB FOR ADVANCED RETINOPATHY OF PREMATURITY-RELATED RETINAL DETACHMENT. Retin Cases Brief Rep. 2016; 10(2):183-6.
    View in: PubMed
    Score: 0.028
  22. Acquired vasoproliferative retinal tumor: a late sequela of retinopathy of prematurity. Arch Ophthalmol. 2011 Sep; 129(9):1234-5.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.